相关实验视频

Updated: Jun 19, 2025

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

通过向SOX-2转录因子,MiRNA-3163限制了卵巢癌类干细胞

Bilash Chatterjee^1,2, Subhankar Bose^1,2, Richa Singh³

¹Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institution of Chemical Biology, Kolkata, West Bengal, India.

Non-coding RNA research

|July 25, 2024

概括

微RNA-3163 (miR-3163) 通过向SOX-2来抑制卵巢癌干细胞 (CSCs). 恢复miR-3163水平可能会提供一种新的策略来防止卵巢癌的化学抵抗和复发.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

癌症干细胞 (CSC) 驱动瘤的进展和耐药性.
微RNAs (miRNAs) 调节CSC的特性,并且是治疗点.
MiR-3163通常充当瘤抑制剂,但其在卵巢CSC中的作用尚不清楚.

研究的目的:

研究miR-3163在调节卵巢CSC表型中的作用.
阐明miR-3163影响卵巢CSCs的机制.

主要方法:

在卵巢CSLC中对miR-3163表达的定量分析.
在miR-3163操纵后进行功能测试 (例如球形形成).
双露西法酶记者测定以确认目标相互作用.

主要成果:

在卵巢癌类干细胞 (CSLCs) 中,MiR-3163的下调显著.
过度表达miR-3163会破坏茎状表型,并抑制球形形成.
米R-3163直接准SOX-2,这是干度的关键调节器.

结论:

米R-3163通过向SOX-2来抑制卵巢CSCs.
恢复miR-3163表达是一种潜在的治疗策略,可以根除CSCs.
这种方法可能有助于克服化学抵抗,并防止卵巢癌的瘤复发.

关键词:

癌症类似干细胞的细胞.这是一个微型RNA.迁徙的潜力迁徙的潜力卵巢癌是发生在卵巢中的癌症.

更多相关视频

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...